Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Now Covered by Barclays

Equities researchers at Barclays started coverage on shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) in a research note issued to investors on Wednesday, Briefing.com reports. The firm set an “equal weight” rating and a $10.00 price target on the stock. Barclays‘s price target would indicate a potential upside of 0.40% from the company’s previous close.

Several other research analysts have also recently issued reports on the company. Wall Street Zen raised Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a report on Saturday, August 8th. Weiss Ratings upgraded Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, September 17th. Finally, Mizuho cut their target price on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 15th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Senseonics Holdings, Inc. Common Stock has an average rating of “Hold” and an average target price of $13.00.

Senseonics Holdings, Inc. Common Stock Stock Performance

Shares of SENS opened at $9.96 on Wednesday. The company has a debt-to-equity ratio of 0.62, a current ratio of 6.74 and a quick ratio of 6.40. The firm’s 50 day moving average is $8.65 and its 200-day moving average is $7.06. Senseonics Holdings, Inc. Common Stock has a 12-month low of $4.79 and a 12-month high of $10.64. The stock has a market capitalization of $416.33 million, a P/E ratio of -4.47 and a beta of 1.02.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last released its earnings results on Thursday, August 6th. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. The business had revenue of $14.48 million for the quarter. Equities research analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.31 EPS for the current fiscal year.

Insider Activity at Senseonics Holdings, Inc. Common Stock

In other news, Director Douglas Roeder purchased 13,953 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction that occurred on Wednesday, August 19th. The stock was acquired at an average price of $8.98 per share, for a total transaction of $125,297.94. Following the transaction, the director owned 171,191 shares in the company, valued at $1,537,295.18. The trade was a 8.87% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 4.70% of the company’s stock.

Institutional Trading of Senseonics Holdings, Inc. Common Stock

Several large investors have recently added to or reduced their stakes in SENS. BlackRock Inc. acquired a new position in Senseonics Holdings, Inc. Common Stock during the second quarter valued at $15,867,000. Masters Capital Management LLC boosted its position in Senseonics Holdings, Inc. Common Stock by 100.0% during the 1st quarter. Masters Capital Management LLC now owns 500,000 shares of the company’s stock worth $3,330,000 after acquiring an additional 250,002 shares during the period. Bank of America Corp DE purchased a new position in Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at about $2,241,000. Readystate Asset Management LP purchased a new position in Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at about $574,000. Finally, Penn Capital Management Company LLC acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at about $535,000. 12.36% of the stock is owned by institutional investors and hedge funds.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing continuous glucose monitoring (CGM) systems for people with diabetes. Its products are designed to measure glucose levels continuously and provide data through a wearable transmitter and mobile application, supporting diabetes management and treatment decisions.

The company’s primary product is the Eversense CGM system, which uses a small sensor implanted under the skin and a removable, rechargeable transmitter worn over the sensor.